Cross-cultural adaptation and validation of Leicester Cough Questionnaire in sarcoidosis: the persian version
CONCLUSIONS: The psychometric properties showed that the Persian version of LCQ is a valid and reliable measure to evaluate cough-specific quality of life and is a fit-for-purpose measure for use in patients with pulmonary sarcoidosis and the results can guide clinicians in treatment decisions.PMID:38567558 | PMC:PMC11008321 | DOI:10.36141/svdld.v41i1.15203 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Mohammad Rahdar Arda Kiani Sima Noorali Arezoo Bakhshandeh Fatemeh Sadat Hosseini-Baharanchi Shadi Shafaghi Atefeh Abedini Amir Behnam Kharazmi Source Type: research
Risk of depression and anxiety in 7.302 patients with sarcoidosis: a nationwide cohort study
CONCLUSIONS: Sarcoidosis cases had a higher risk of A/D compared with matched comparators during 18 years of follow-up. The risk of developing A/D was greater for male and female cases and within all age-groups compared with the matched comparators.PMID:38567557 | PMC:PMC11008320 | DOI:10.36141/svdld.v41i1.15213 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Melina Gade Sikj ær Ole Hilberg Ingeborg Farver-Vestergaard Rikke Ibsen Anders L økke Source Type: research
Diagnostic yield of the Kveim test in sarcoidosis patients
CONCLUSIONS: Conventional laboratory modalities were useful for the assessment of disease activity and identification of organ involvement. Kveim test revealed a significant diagnostic yield for all stages of sarcoidosis. The lowest output was achieved in stage IV patients due to the waning of active granulomatous inflammation. The highest diagnostic sensitivity was obtained by an integrated analysis of the conventional laboratory and the Kveim test results for all aspects of sarcoidosis.PMID:38567556 | PMC:PMC11008327 | DOI:10.36141/svdld.v41i1.15253 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Cuneyt Tetikkurt Emre Yanardag Muammer Bilir Halil Yanardag Ugur Kimyon Source Type: research
Prognostic significance of antifibrotic agents in idiopathic pulmonary fibrosis after initiation of long-term oxygen therapy
CONCLUSION: In IPF patients who were introduced LTOT, treatment with antifibrotic agents was the independent factor for favorable survival. Treatment with antifibrotic agents may improve prognosis of IPF even after initiation of LTOT.PMID:38567555 | PMC:PMC11008323 | DOI:10.36141/svdld.v41i1.15264 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Mayuko Ishiwari Yuta Kono Yuki Togashi Kenichi Kobayashi Ryota Kikuchi Mariko Kogami Shinji Abe Source Type: research
Flashy lungs and sarcoidosis: not always a sign of disease activity
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26;41(1):e2024010. doi: 10.36141/svdld.v41i1.14626.ABSTRACTThis is the case of a 68-year-old man with known cardiac sarcoidosis undergoing treatment with methotrexate who presented with new onset of dyspnea and lipothymia. FDG-PET/CT revealed pathological uptake within lung parenchyma which resolved following discontinuation of methotrexate, compatible with methotrexate-induced pneumonitis. This is the first case of methotrexate-induced pneumonitis documented by FDG-PET/CT.PMID:38567563 | PMC:PMC11008334 | DOI:10.36141/svdld.v41i1.14626 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Yousif A Lucinian Patrick Martineau Francois Harel Matthieu Pelletier-Galarneau Source Type: research
